Long‐term follow‐up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment
暂无分享,去创建一个
[1] J. Brooks,et al. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.
[2] Kathleen A Cronin,et al. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics , 2018, Cancer.
[3] Jong Y. Park,et al. African‐American men and prostate cancer‐specific mortality: a competing risk analysis of a large institutional cohort, 1989–2015 , 2018, Cancer medicine.
[4] K. Ballman,et al. National trends in management of localized prostate cancer: A population based analysis 2004‐2013 , 2018, The Prostate.
[5] J. King,et al. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014. , 2018, Annals of epidemiology.
[6] Ronald C. Chen,et al. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options , 2017, The Journal of urology.
[7] M. Terris,et al. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database , 2017, Cancer.
[8] M. Cooperberg,et al. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years , 2017, JAMA.
[9] Mufaddal Mamawala,et al. Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] D. Schwartz,et al. A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease? , 2015, Clinical genitourinary cancer.
[11] A. Partin,et al. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up. , 2014, Urology.
[12] E. Castle,et al. Racial disparities in survival for patients with clinically localized prostate cancer adjusted for treatment effects. , 2014, Mayo Clinic proceedings.
[13] H. Parnes,et al. Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial , 2014, BJU international.
[14] J. Concato,et al. 'Race' and prostate cancer mortality in equal-access healthcare systems. , 2013, The American journal of medicine.
[15] R. V. D. van den Bergh,et al. Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer , 2012, BJU international.
[16] Yongmei Chen,et al. Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system , 2011, BJU international.
[17] John D. Roberts,et al. Do African American Men Have Lower Survival From Prostate Cancer Compared With White Men? A Meta-analysis , 2010, American journal of men's health.
[18] M. Cooperberg,et al. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. , 2009, Journal of the National Cancer Institute.
[19] Xianglin L. Du,et al. Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer. , 2009, Cancer control : journal of the Moffitt Cancer Center.
[20] M. Symons,et al. Racial Differences in Clinical Progression Among Medicare Recipients After Treatment for Localized Prostate Cancer (United States) , 2006, Cancer Causes & Control.
[21] James A Hanley,et al. 20-year outcomes following conservative management of clinically localized prostate cancer. , 2005, JAMA.
[22] H. Brenner,et al. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Paul W Dickman,et al. Natural history of early, localized prostate cancer. , 2004, JAMA.
[24] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[25] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[26] Michael K Gould,et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. , 2012, The Permanente journal.